High-dose intravenous interferon-beta in multiple sclerosis patients with high-titer neutralizing antibodies (HINABS

H Hegen1, M Guger2, A Harrer3

  • 1Innsbruck Medical University, Department of Neurology, Anichstraße 35, 6020 Innsbruck, Austria.

Abstract